clinical trial

Yantai LNC Biotechnology to Use Sofie Biosciences Imaging Agent to ID Patients for Theranostic Trial

Lantern Pharma Preparing IND for Synthetic Lethality Program With FDA Feedback

Bio4t2 Begins Dosing Solid Tumor Patients in First-In-Human CAR T-Cell Therapy Trial

Immunocore Unveils New T-Cell Receptor Therapy Candidates, Estimates $140M in 2022 Kimmtrak Sales

Ideaya to Launch PARG Inhibitor Trial in Homologous Recombination Repair-Deficient Cancers

BioNTech, UK Government to Expand Access to Personalized mRNA Cancer Vaccines in England

Theseus Reveals Development Milestones for its Precision Oncology Programs in 2023

Orano Med Commences Phase I Trial of Lead Radiopharmaceutical in GRPR-Expressing Solid Tumors

Evaxion Cleared by FDA to Begin Phase IIb Trial of Cancer Vaccine, Keytruda in Melanoma

FDA Clears Iaso Biotherapeutics for US Trials of BCMA-Targeted CAR-T Therapy in Multiple Myeloma

OneChain Immunotherapeutics to Launch CD1a-Targeting CAR T-Cell Therapy Trial in T-Cell Leukemia

Jazz Takes Up Option on Zymeworks' HER2-Targeted Bispecific Antibody

Invectys, CTMC Begin First-in-Human Trial of HLA-G-Targeting CAR T-Cell Therapy in Solid Tumors

AstraZeneca's Imfinzi Fails to Meet Primary Endpoint in PD-L1-high NSCLC

Carrick Therapeutics, Menarini Group Studying Samuraciclib With Elacestrant

AnHeart Therapeutics Gets FDA Clearance to Study Safusidenib in IDH1-Mutant Glioma Patients

Ellipses Begins Phase I/II Trial of EP0031 in RET-Altered Tumors